Ignite Creation Date:
2025-12-24 @ 3:40 PM
Ignite Modification Date:
2025-12-26 @ 8:38 AM
Study NCT ID:
NCT05428592
Status:
UNKNOWN
Last Update Posted:
2023-02-02
First Post:
2022-06-14
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Clinical Trial of SARS-CoV-2 mRNA Vaccine(LVRNA009) as Heterologous Booster in Islamabad
Sponsor:
AIM Vaccine Co., Ltd.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-04
Start Date Type:
ESTIMATED
Primary Completion Date:
2023-10
Primary Completion Date Type:
ESTIMATED
Completion Date:
2024-10
Completion Date Type:
ESTIMATED
First Submit Date:
2022-06-14
First Submit QC Date:
None
Study First Post Date:
2022-06-23
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-02-01
Last Update Post Date:
2023-02-02
Last Update Post Date Type:
ACTUAL